NRC Health Dividends Per Share
NRC Health (NRC) reported Dividends Per Share of $0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareDeclared · last filed 2026-08-04
- NRC Health common stock, dividends, per share, declared for the quarter ending 2026-06-30 was $0.16, a 33.33% increase year-over-year.
- NRC Health common stock, dividends, per share, declared for the quarter ending 2026-03-31 was $0.16, a 33.33% increase year-over-year.
- NRC Health common stock, dividends, per share, declared for the quarter ending 2025-09-30 was $0.12, a 0.00% change year-over-year.
- NRC Health common stock, dividends, per share, declared for the quarter ending 2025-06-30 was $0.12, a 0.00% change year-over-year.
- NRC Health common stock, dividends, per share, declared for fiscal 2025 was $0.52, a 8.33% increase from fiscal 2024.
- NRC Health common stock, dividends, per share, declared for fiscal 2024 was $0.48, a 67.57% decline from fiscal 2023.
- NRC Health common stock, dividends, per share, declared for fiscal 2023 was $1.48, a 76.19% increase from fiscal 2022.
- NRC Health common stock, dividends, per share, declared for fiscal 2022 was $0.84, a 75.00% increase from fiscal 2021.
| Period end | Common Stock, Dividends, Per Share, Declared 3 month | Common Stock, Dividends, Per Share, Declared 6 month | Common Stock, Dividends, Per Share, Declared 9 month | Common Stock, Dividends, Per Share, Declared 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.16 10-Q · filed 2026-08-04 | $0.32 derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $0.16 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $0.52 10-K · filed 2026-03-05 | |||
| 2025-09-30 | $0.12 10-Q · filed 2025-11-07 | $0.24 derived: sum of 2 quarters · filed 2026-08-04 | $0.36 derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-06-30 | $0.12 10-Q · filed 2026-08-04 | $0.24 derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $0.12 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $0.48 10-K · filed 2026-03-05 | |||
| 2024-09-30 | $0.12 10-Q · filed 2025-11-07 | $0.24 derived: sum of 2 quarters · filed 2025-11-07 | $0.36 derived: sum of 3 quarters · filed 2025-11-07 | |
| 2024-06-30 | $0.12 10-Q · filed 2025-11-07 | $0.24 derived: sum of 2 quarters · filed 2025-11-07 | ||
| 2024-03-31 | $0.12 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $1.48 10-K · filed 2026-03-05 | |||
| 2023-09-30 | $1.12 10-Q · filed 2024-11-08 | $1.24 derived: sum of 2 quarters · filed 2024-11-08 | $1.36 derived: sum of 3 quarters · filed 2024-11-08 | |
| 2023-06-30 | $0.12 10-Q · filed 2024-11-08 | $0.24 derived: sum of 2 quarters · filed 2024-11-08 | ||
| 2023-03-31 | $0.12 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $0.84 10-K · filed 2025-03-17 | |||
| 2022-09-30 | $0.24 10-Q · filed 2023-11-09 | $0.48 derived: sum of 2 quarters · filed 2023-11-09 | $0.72 derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $0.24 10-Q · filed 2023-11-09 | $0.48 derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $0.24 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $0.48 10-K · filed 2024-02-27 | |||
| 2021-09-30 | $0.12 10-Q · filed 2022-11-04 | $0.36 derived: sum of 2 quarters · filed 2022-11-04 | ||
| 2021-06-30 | $0.24 10-Q · filed 2022-11-04 | |||
| 2020-12-31 | $0.21 10-K · filed 2023-03-03 | |||
| 2020-03-31 | $0.21 10-Q · filed 2021-11-05 | |||
| 2019-12-31 | $0.78 10-K · filed 2022-03-04 | |||
| 2019-09-30 | $0.19 10-Q · filed 2020-11-06 | $0.38 derived: sum of 2 quarters · filed 2020-11-06 | $0.57 derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $0.19 10-Q · filed 2020-11-06 | $0.38 derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2019-03-31 | $0.19 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |